| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Department of Molecular Microbiology and Immunology, University of Missouri School of Medicine, Columbia, MO 65212; and
Division of Immunology and Rheumatology, Department of Internal Medicine, University of Missouri School of Medicine, and the Medical Research Service, Veterans Affairs Medical Center, Columbia, MO 65212
The ability of two different human professional APCs, specifically
macrophages (M
) and dendritic cells (DC), to stimulate primary
responses in human CD8+ T lymphocytes was examined using
both allogeneic and Ag-pulsed autologous APCs. CTL responses in
CD8+ T lymphocytes isolated from HIV-uninfected donors were
evaluated against six different HIV epitopes that are restricted by
four different HLA alleles using autologous human PBMC-derived M and
DCs for primary stimulation. In a side-by-side experiment, immature
DCs, but not M, were able to prime a CTL response against the
B14-restricted p24gag 298–306 epitope; mature DCs were also
able to prime a response against this epitope. In addition, DCs were
capable of priming CD8+ CTL responses against the
B8-restricted p24gag 259–267 epitope. In
contrast, M were unable to prime strong CTL responses against other
epitopes. Since the Ag-specific cytotoxic responses required subsequent
rounds of restimulation before they could be detected, the ability of
the allogeneic M and DCs to directly prime CD8+ T
lymphocyte responses without subsequent restimulation was examined.
Similar to the aforementioned peptide-specific results, DCs were more
efficient than M in priming both allogeneic proliferative and
cytotoxic responses in human CD8+ T lymphocytes.
Collectively, these results promote an enhanced status for DCs in the
primary stimulation of human CD8+ T
lymphocytes.
This article has been cited by other articles:
|
|
 |
|
  N. Hirano, M. O. Butler, Z. Xia, S. Ansen, M. S. von Bergwelt-Baildon, D. Neuberg, G. J. Freeman, and L. M. Nadler Engagement of CD83 ligand induces prolonged expansion of CD8+ T cells and preferential enrichment for antigen specificity Blood, February 15, 2006; 107(4): 1528 - 1536. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Yang, K.-Y. Tsang, and J. Schlom Induction of Higher-Avidity Human CTLs by Vector-Mediated Enhanced Costimulation of Antigen-Presenting Cells Clin. Cancer Res., August 1, 2005; 11(15): 5603 - 5615. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X.-L. Huang, Z. Fan, B. A. Colleton, R. Buchli, H. Li, W. H. Hildebrand, and C. R. Rinaldo Jr. Processing and Presentation of Exogenous HLA Class I Peptides by Dendritic Cells from Human Immunodeficiency Virus Type 1-Infected Persons J. Virol., March 1, 2005; 79(5): 3052 - 3062. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Palena, M. Zhu, J. Schlom, and K.-Y. Tsang Human B cells that hyperexpress a triad of costimulatory molecules via avipox-vector infection: an alternative source of efficient antigen-presenting cells Blood, July 1, 2004; 104(1): 192 - 199. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. G. Kitchen, N. R. Jones, S. LaForge, J. K. Whitmire, B.-A. Vu, Z. Galic, D. G. Brooks, S. J. Brown, C. M. R. Kitchen, and J. A. Zack CD4 on CD8+ T cells directly enhances effector function and is a target for HIV infection PNAS, June 8, 2004; 101(23): 8727 - 8732. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Kan-Mitchell, B. Bisikirska, F. Wong-Staal, K. L. Schaubert, M. Bajcz, and M. Bereta The HIV-1 HLA-A2-SLYNTVATL Is a Help-Independent CTL Epitope J. Immunol., May 1, 2004; 172(9): 5249 - 5261. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Vankayalapati, P. Klucar, B. Wizel, S. E. Weis, B. Samten, H. Safi, H. Shams, and P. F. Barnes NK Cells Regulate CD8+ T Cell Effector Function in Response to an Intracellular Pathogen J. Immunol., January 1, 2004; 172(1): 130 - 137. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. von Bergwelt-Baildon, R. H. Vonderheide, B. Maecker, N. Hirano, K. S. Anderson, M. O. Butler, Z. Xia, W. Y. Zeng, K. W. Wucherpfennig, L. M. Nadler, et al. Human primary and memory cytotoxic T lymphocyte responses are efficiently induced by means of CD40-activated B cells as antigen-presenting cells: potential for clinical application Blood, May 1, 2002; 99(9): 3319 - 3325. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. Rudolf, S. C. Fausch, D. M. Da Silva, and W. M. Kast Human Dendritic Cells Are Activated by Chimeric Human Papillomavirus Type-16 Virus-Like Particles and Induce Epitope-Specific Human T Cell Responses In Vitro J. Immunol., May 15, 2001; 166(10): 5917 - 5924. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Stager, D. F. Smith, and P. M. Kaye Immunization with a Recombinant Stage-Regulated Surface Protein from Leishmania donovani Induces Protection Against Visceral Leishmaniasis J. Immunol., December 15, 2000; 165(12): 7064 - 7071. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Weissman, H. Ni, D. Scales, A. Dude, J. Capodici, K. McGibney, A. Abdool, S. N. Isaacs, G. Cannon, and K. Kariko HIV Gag mRNA Transfection of Dendritic Cells (DC) Delivers Encoded Antigen to MHC Class I and II Molecules, Causes DC Maturation, and Induces a Potent Human In Vitro Primary Immune Response J. Immunol., October 15, 2000; 165(8): 4710 - 4717. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Larsson, D. Messmer, S. Somersan, J.-F. Fonteneau, S. M. Donahoe, M. Lee, P. R. Dunbar, V. Cerundolo, I. Julkunen, D. F. Nixon, et al. Requirement of Mature Dendritic Cells for Efficient Activation of Influenza A-Specific Memory CD8+ T Cells J. Immunol., August 1, 2000; 165(3): 1182 - 1190. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. R. Drake III, J. M. Moser, A. Hadley, J. D. Altman, C. Maliszewski, E. Butz, and A. E. Lukacher Polyomavirus-Infected Dendritic Cells Induce Antiviral CD8+ T Lymphocytes J. Virol., May 1, 2000; 74(9): 4093 - 4101. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
